The future of mRNA vaccines looks bright with or without Donald Trump. These groundbreaking shots have proven their efficacy against Covid-19 and hold promise for tackling a range of other diseases, including flu, HIV, and cancer.
However, the US government's recent decision to cut funding for mRNA research has sent shockwaves through the scientific community. The move, driven by the anti-science and anti-vaccine agenda of Health Secretary Robert F Kennedy Jr., threatens to undermine the very progress that has been made with these vaccines.
It is ironic that the most ambitious work on mRNA cancer vaccines has escaped the Trump administration's notice, leaving companies to develop personalized treatments without government support. This is a critical moment for the technology, and the US must not be allowed to jeopardize its success.
The EU and UK are already stepping up to fill the gap left by the US government. The European Commission has pledged €500m to recruit American scientists who have been driven away by the Trump administration's policies, while France has added another €100m to the fund. These efforts demonstrate that the world is not willing to let a single country's anti-science agenda dictate the course of scientific progress.
As the US abandons its support for mRNA research, it will be left behind as other countries take up the mantle. The future of vaccination depends on the global effort to develop and distribute these life-saving shots. Without international cooperation, we risk losing the momentum that has already been gained with mRNA vaccines.
However, the US government's recent decision to cut funding for mRNA research has sent shockwaves through the scientific community. The move, driven by the anti-science and anti-vaccine agenda of Health Secretary Robert F Kennedy Jr., threatens to undermine the very progress that has been made with these vaccines.
It is ironic that the most ambitious work on mRNA cancer vaccines has escaped the Trump administration's notice, leaving companies to develop personalized treatments without government support. This is a critical moment for the technology, and the US must not be allowed to jeopardize its success.
The EU and UK are already stepping up to fill the gap left by the US government. The European Commission has pledged €500m to recruit American scientists who have been driven away by the Trump administration's policies, while France has added another €100m to the fund. These efforts demonstrate that the world is not willing to let a single country's anti-science agenda dictate the course of scientific progress.
As the US abandons its support for mRNA research, it will be left behind as other countries take up the mantle. The future of vaccination depends on the global effort to develop and distribute these life-saving shots. Without international cooperation, we risk losing the momentum that has already been gained with mRNA vaccines.